Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-21

Clinical Trial Update: Changes in Renal and Splanchnic Oxygenation During Ibuprofen Treatment for Patent Ductus Arterious

View source ↗

Summary

A completed clinical trial investigating how ibuprofen treatment for patent ductus arteriosus affects renal and splanchnic oxygenation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Ductus Arteriosus, Patent | Status: COMPLETED